Caricamento...
Augmenting extinction learning with d-cycloserine reduces return of fear: a randomized, placebo-controlled fMRI study
d-cycloserine (DCS), a partial NMDA-receptor agonist, seems to be a promising enhancer for exposure therapy in anxiety disorders. It has been tested successfully in animal models of fear extinction, where DCS enhanced extinction learning. Applied in clinical studies, results of DCS-augmented exposur...
Salvato in:
| Pubblicato in: | Neuropsychopharmacology |
|---|---|
| Autori principali: | , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Springer International Publishing
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6969173/ https://ncbi.nlm.nih.gov/pubmed/31634897 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41386-019-0552-z |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|